Provider Perspectives on Adolescent Confidentiality and the Electronic Health Record Postimplementation of the 21st Century Cures Act Final Rule.

Autor: Goldstein RL; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California. Electronic address: rachelg2@stanford.edu., Mermelstein SJ; Division of Adolescent Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri., Sisk BA; Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri; Bioethics Research Center, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri., Carlson JL; Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.

Publikováno v: The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2024 Nov; Vol. 75 (5), pp. 725-729. Date of Electronic Publication: 2023 Dec 13.

Disparities in electronic health record patient portal activation and use among people with hematological malignancies.

Autor: Trammel AM; Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO, USA., Sisk BA; Division of Oncology, Washington University School of Medicine, St Louis, MO, USA., Fiala MA; Division of Oncology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: mfiala@wustl.edu.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Oct 22, pp. 102135. Date of Electronic Publication: 2024 Oct 22.

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.

Autor: Parekh D; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Lin H; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Batajoo A; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Peckham-Gregory E; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Karri V; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Stanton W; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Scull B; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Fleishmann R; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., El-Mallawany N; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Eckstein OS; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Prudowsky ZD; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Gulati N; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA., Agrusa JE; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.; Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA., Ahmed AZ; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Chu R; Division of Hematology/Oncology/BMT, Central Michigan University College of Medicine, Children's Hospital of Michigan, Detroit, Michigan, USA., Dietz MS; Division of Pediatric Hematology and Oncology, University of Utah, Primary Children's Hospital, Salt Lake City, Utah, USA., Goldman SC; Pediatric Hematology/Oncology, Medical City Children's Hospital, Dallas, Texas, USA., Hogarty MD; Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Imran H; Department of Pediatrics, University of South Alabama, Mobile, Alberta, USA., Intzes S; Department of Pediatric Hematology/Oncology, Sacred Heart Children's Hospital, Spokane, Washington, USA., Kim JM; Department of Pediatrics, Division of Hematology/Oncology, University of California San Diego School of Medicine, Rady Children's Hospital, San Diego, California, USA., Kopp LM; Department of Pediatrics, University of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, Arizona, USA., Levy CF; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Cohen Children's Medical Center, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA., Neff P; Children's Blood and Cancer Center, The University of Texas at Austin, Dell Children's Medical Center of Central Texas, Austin, Texas, USA., Pillai PM; Jack Martin Division of Pediatric Hematology-Oncology, Jack and Lucy Clark Department of Pediatrics, Mount Sinai Kravis Children's Hospital, New York, New York, USA., Sisk BA; Division of Pediatric Hematology and Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Schiff DE; Department of Pediatrics, Division of Hematology/Oncology, University of California San Diego School of Medicine, Rady Children's Hospital, San Diego, California, USA., Trobaugh-Lotrario AD; Department of Pediatric Hematology/Oncology, Sacred Heart Children's Hospital, Spokane, Washington, USA., Walkovich K; Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA., McClain KL; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Allen CE; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1888-1893. Date of Electronic Publication: 2024 Mar 19.

An Overarching Framework for the Ethics of Artificial Intelligence in Pediatrics.

Autor: Sisk BA; Bioethics Research Center, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.; Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri., Antes AL; Bioethics Research Center, Department of Medicine, Washington University School of Medicine, St Louis, Missouri., DuBois JM; Bioethics Research Center, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.

Publikováno v: JAMA pediatrics [JAMA Pediatr] 2024 Mar 01; Vol. 178 (3), pp. 213-214.

Designing and validating novel communication measures for pediatric, adolescent, and young adult oncology care and research: The PedCOM measures.

Autor: Sisk BA; Department of Pediatrics and Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Newman AR; Marquette University, Milwaukee, Wisconsin, USA.; Children's Wisconsin, Milwaukee, Wisconsin, USA., Chen D; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA., Mack JW; Department of Pediatric Oncology and Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Dec; Vol. 70 (12), pp. e30685. Date of Electronic Publication: 2023 Sep 23.